Suspected adverse reactions to oral administration of a praziquantel-pyrantel combination in captive cheetahs (Acinonyx jubatus)

Katherine M. Whitehouse-Tedd Cheetah Outreach, Quinan House, Paardevlei, De Beers Street, Somerset West, Western Cape 7137, South Africa.
School of Animal, Rural and Environmental Sciences, Nottingham Trent University, Southwell, Nottinghamshire, NG23 0QF, England.

Search for other papers by Katherine M. Whitehouse-Tedd in
Current site
Google Scholar
PubMed
Close
 PhD
,
Liesl Smith Cheetah Outreach, Quinan House, Paardevlei, De Beers Street, Somerset West, Western Cape 7137, South Africa.

Search for other papers by Liesl Smith in
Current site
Google Scholar
PubMed
Close
 BSc
,
Jane A. Budd Breeding Centre for Endangered Arabian Wildlife, PO Box 29922, Sharjah, United Arab Emirates.

Search for other papers by Jane A. Budd in
Current site
Google Scholar
PubMed
Close
 BVMS
, and
Christopher G. Lloyd Two Feet Four Paws Veterinary Clinic, Al Durar Building, Dubailand Residence Complex, Dubai, United Arab Emirates.

Search for other papers by Christopher G. Lloyd in
Current site
Google Scholar
PubMed
Close
 BVSc, MSc

Abstract

OBJECTIVE To characterize adverse reactions to oral administration of a combination of praziquantel and pyrantel embonate or pyrantel pamoate, with or without oxantel embonate, in captive cheetahs (Acinonyx jubatus).

DESIGN Retrospective case series and case-control study.

ANIMALS 16 captive cheetahs with signs of adverse reaction to oral administration of praziquantel and pyrantel, with or without oxantel embonate (affected group), and 27 cheetahs without such reactions (unaffected group), all from 3 independent facilities.

PROCEDURES Medical records and postmortem findings for affected cheetahs were reviewed and compared with those of unaffected animals. Anthelmintic doses administered, age, and sex of cheetahs were compared between groups.

RESULTS 3 reactions in affected cheetahs were fatal, whereas the remainder ranged from mild to severe. Postmortem examination failed to reveal any disease processes or conditions to explain the deaths. No differences in anthelmintic dose were identified between affected and unaffected cheetahs for all facilities combined, and no correlation existed between dose and reaction severity. No association with sex was detected, but affected cheetahs were significantly younger than unaffected cheetahs. This difference was not significant after controlling for facility.

CONCLUSIONS AND CLINICAL RELEVANCE Cheetahs were concluded to have had an adverse reaction to the praziquantel-pyrantel combination because of temporal proximity of onset of clinical signs to dose administration, similarity of signs to those reported for toxicosis in other species for these drugs, and a lack of other disease process or environmental explanatory factors. A highly cautious approach to the use of this drug combination is recommended for cheetahs.

Abstract

OBJECTIVE To characterize adverse reactions to oral administration of a combination of praziquantel and pyrantel embonate or pyrantel pamoate, with or without oxantel embonate, in captive cheetahs (Acinonyx jubatus).

DESIGN Retrospective case series and case-control study.

ANIMALS 16 captive cheetahs with signs of adverse reaction to oral administration of praziquantel and pyrantel, with or without oxantel embonate (affected group), and 27 cheetahs without such reactions (unaffected group), all from 3 independent facilities.

PROCEDURES Medical records and postmortem findings for affected cheetahs were reviewed and compared with those of unaffected animals. Anthelmintic doses administered, age, and sex of cheetahs were compared between groups.

RESULTS 3 reactions in affected cheetahs were fatal, whereas the remainder ranged from mild to severe. Postmortem examination failed to reveal any disease processes or conditions to explain the deaths. No differences in anthelmintic dose were identified between affected and unaffected cheetahs for all facilities combined, and no correlation existed between dose and reaction severity. No association with sex was detected, but affected cheetahs were significantly younger than unaffected cheetahs. This difference was not significant after controlling for facility.

CONCLUSIONS AND CLINICAL RELEVANCE Cheetahs were concluded to have had an adverse reaction to the praziquantel-pyrantel combination because of temporal proximity of onset of clinical signs to dose administration, similarity of signs to those reported for toxicosis in other species for these drugs, and a lack of other disease process or environmental explanatory factors. A highly cautious approach to the use of this drug combination is recommended for cheetahs.

Supplementary Materials

    • Supplementary Table S1 (PDF 971 kb)
All Time Past Year Past 30 Days
Abstract Views 299 0 0
Full Text Views 1292 1031 73
PDF Downloads 256 83 8
Advertisement